These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3735855)

  • 1. [Clinical statistics of the bladder tumor].
    Matsuda M; Tada Y; Nakano E; Fujioka H; Takaha M; Sonoda T; Kotake T; Osafune M
    Nihon Hinyokika Gakkai Zasshi; 1986 Feb; 77(2):208-19. PubMed ID: 3735855
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statistical studies on the recurrence rate in superficial bladder tumor].
    Matsuoka K; Ueda S; Ooyabu Y; Fujii Y; Noda S; Eto K
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):850-8. PubMed ID: 4068426
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Palou et al.: Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. (Urology 2009;73:1313-1317).
    Bryan RT; Cheng KK; Wallace DM
    Urology; 2009 Sep; 74(3):714. PubMed ID: 19716932
    [No Abstract]   [Full Text] [Related]  

  • 4. [Retrospective study of the incidence of recurrences at 6 months in the treatment of transitional bladder tumors].
    Frea B; Tizzani A; Cocimano V; Tasso M; Biancardi L
    Minerva Urol Nefrol; 1984; 36(3):237-9. PubMed ID: 6533831
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenocarcinoma and transitional cell carcinoma occurring simultaneously in the urinary bladder (mixed tumor).
    Fegen JP; Albert DJ; Persky L
    J Surg Oncol; 1971; 3(4):387-92. PubMed ID: 5097621
    [No Abstract]   [Full Text] [Related]  

  • 6. Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.
    Schwalb MD; Herr HW; Sogani PC; Russo P; Sheinfeld J; Fair WR
    J Urol; 1994 Aug; 152(2 Pt 1):382-7. PubMed ID: 8015076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years.
    Holmäng S; Hedelin H; Anderström C; Johansson SL
    J Urol; 1995 Jun; 153(6):1823-6; discussion 1826-7. PubMed ID: 7752327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary management of stage T1 transitional cell carcinoma of the bladder.
    Sataa S; Yassine N; Ghassen HH; Imed BS; Mohamed C; Maher C; Ali H
    Tunis Med; 2005 Dec; 83 Suppl 12():87-9. PubMed ID: 16430077
    [No Abstract]   [Full Text] [Related]  

  • 9. Bladder tumours in Enugu, Nigeria.
    Aghaji AE; Mbonu OO
    Br J Urol; 1989 Oct; 64(4):399-402. PubMed ID: 2819392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urothelial tumors of the bladder in patients less than 25 years of age].
    Kostakopoulos A; Stavropoulos N; Gavras P; Macrichoritis C; Deliveliotis C
    Prog Urol; 1993; 3(4):618-20. PubMed ID: 8401622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder carcinoma in patients age 40 years or younger.
    Wan J; Grossman HB
    Cancer; 1989 Jul; 64(1):178-81. PubMed ID: 2731112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated tissue inflammatory reaction and eosinophilia in primary superficial bladder cancer.
    Flamm J
    Urology; 1992 Aug; 40(2):180-5. PubMed ID: 1502760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between patient age and superficial transitional cell carcinoma characteristics.
    Shi B; Zhang K; Zhang J; Chen J; Zhang N; Xu Z
    Urology; 2008 Jun; 71(6):1186-90. PubMed ID: 18372010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades.
    Mariappan P; Smith G; Lamb AD; Grigor KM; Tolley DA
    J Urol; 2007 Mar; 177(3):867-75; discussion 875. PubMed ID: 17296362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial comment on: significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients.
    Sagalowsky AI
    Eur Urol; 2008 Nov; 54(5):1134-5. PubMed ID: 18243496
    [No Abstract]   [Full Text] [Related]  

  • 16. Superficial bladder carcinoma. Factors affecting the natural history.
    Fitzpatrick JM
    World J Urol; 1993; 11(3):142-7. PubMed ID: 8401631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravesical therapy: does it affect the natural history of superficial bladder cancer?
    Lamm DL; Griffith JG
    Semin Urol; 1992 Feb; 10(1):39-44. PubMed ID: 1565903
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bladder tumors in young patients].
    Aboutaieb R; Dakir M; Sarrf I; el Moussaoui A; Bennani S; el Mrini M; Meziane F; Benjelloun S
    Prog Urol; 1998 Feb; 8(1):43-6. PubMed ID: 9533150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local recurrence and progression of non-muscle-invasive bladder cancer in Sweden: a population-based follow-up study.
    Liedberg F; Hagberg O; Holmäng S; Hosseini Aliabad A; Jancke G; Ljungberg B; Malmström PU; Åberg H; Jahnson S
    Scand J Urol; 2015; 49(4):290-5. PubMed ID: 25624049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of superficial bladder carcinoma.
    Fitzpatrick JM
    Semin Urol; 1993 Aug; 11(3):127-36. PubMed ID: 8210834
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.